MEI Revenue Per Share from 2010 to 2025

MEIP Stock  USD 2.43  0.03  1.22%   
MEI Pharma Revenue Per Share yearly trend continues to be relatively stable with very little volatility. Revenue Per Share is likely to grow to 9.26 this year. Revenue Per Share is the amount of revenue generated by MEI Pharma per share of stock, calculated by dividing total revenue by the average number of shares outstanding. View All Fundamentals
 
Revenue Per Share  
First Reported
2010-12-31
Previous Quarter
8.82
Current Value
9.26
Quarterly Volatility
4.05929477
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MEI Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEI Pharma's main balance sheet or income statement drivers, such as Interest Expense of 310.3 K, Selling General Administrative of 28.1 M or Total Revenue of 78.8 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.49 or PTB Ratio of 0.63. MEI financial statements analysis is a perfect complement when working with MEI Pharma Valuation or Volatility modules.
  
Check out the analysis of MEI Pharma Correlation against competitors.
To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.

Latest MEI Pharma's Revenue Per Share Growth Pattern

Below is the plot of the Revenue Per Share of MEI Pharma over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. MEI Pharma's Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MEI Pharma's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 010 Years Trend
Slightly volatile
   Revenue Per Share   
       Timeline  

MEI Revenue Per Share Regression Statistics

Arithmetic Mean8.89
Geometric Mean7.24
Coefficient Of Variation45.68
Mean Deviation3.31
Median9.80
Standard Deviation4.06
Sample Variance16.48
Range11.8051
R-Value(0.46)
Mean Square Error13.93
R-Squared0.21
Significance0.07
Slope(0.39)
Total Sum of Squares247.17

MEI Revenue Per Share History

2025 9.26
2024 8.82
2023 9.8
2022 7.33
2021 6.54
2020 4.54
2019 6.35

About MEI Pharma Financial Statements

MEI Pharma shareholders use historical fundamental indicators, such as Revenue Per Share, to determine how well the company is positioned to perform in the future. Although MEI Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in MEI Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on MEI Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Revenue Per Share 8.82  9.26 

Additional Tools for MEI Stock Analysis

When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.